Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccination in high-risk newborns for prevention of atopic disease
NL-OMON20850Active, not recruiting
- Sponsor
- Dutch Research Council
- Start
- Jan 1999
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, single-blind trial in atopic disease and asthma comparing BCG vaccine with Placebo (2 arms). Primary endpoint: Incidence and severity of atopic disease at age 4 years. Started Jan 1999; status: active, not recruiting.
02
Drugs
bcg vaccine
03
Conditions
atopic diseaseasthma
Beyond the preview
Go deeper on NL-OMON20850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20850.